Importantly, we have for the first time demonstrated that metformin can prevent precancerous progression through inhibiting STAT3-mediated signaling pathways in a MNU-induced orthotopic rat bladder cancer model. The gene discussed is STAT3; the disease is urinary bladder cancer.